Identification of Selected <i>in vitro</i>-Generated Phase-I Metabolites of the Steroidal Selective Androgen Receptor Modulator MK-0773 for Doping Control Purposes
Research into developing anabolicagents for various therapeutic purposes has been pursued for decades. As the clinical utility of anabolic–androgenic steroids has been found to be limited because of their lack of tissue selectivity and associated off-target effects, alternative drug entities have been designed and are commonly referred to as selective androgen receptor modulators (SARMs). While most